Logo

UHS

Universal Health Services, Inc.

UHS

Universal Health Services, Inc. • NYSE
$243.63 ▼ -0.23% (-0.55)
Market Cap $15.71 B
52w High $246.33
52w Low $152.33
Dividend Yield 0.80%
P/E 11.6
Volume 541.17K
Outstanding Shares 64.47M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $4.495B ▲ $3.559B ▲ $372.957M ▲ 8.297% ▲ $5.8 ▲ $690.377M ▲
Q2-2025 $4.284B ▲ $3.365B ▲ $353.218M ▲ 8.245% ▲ $5.49 ▲ $659.85M ▲
Q1-2025 $4.1B ▼ $3.242B ▲ $316.68M ▼ 7.724% ▼ $4.87 ▼ $607.984M ▼
Q4-2024 $4.114B ▲ $3.235B ▲ $332.397M ▲ 8.08% ▲ $5.07 ▲ $623.953M ▲
Q3-2024 $3.963B $3.189B $258.714M 6.528% $3.89 $534.873M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $112.895M ▼ $15.344B ▲ $8.046B ▲ $7.23B ▲
Q2-2025 $137.595M ▲ $14.986B ▲ $7.84B ▼ $7.03B ▲
Q1-2025 $126.753M ▲ $14.875B ▲ $7.99B ▲ $6.786B ▲
Q4-2024 $125.983M ▲ $14.47B ▲ $7.707B ▲ $6.666B ▲
Q3-2024 $106.077M $14.354B $7.667B $6.606B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $1.063B ▲ $1.29B ▲ $-846.651M ▼ $-453.592M ▼ $-8.149M ▼ $555.772M ▲
Q2-2025 $353.218M ▲ $548.978M ▲ $-305.939M ▼ $-227.651M ▼ $10.842M ▲ $282.964M ▲
Q1-2025 $316.68M ▼ $360.048M ▼ $-271.299M ▼ $-91.42M ▲ $-1.026M ▼ $121.022M ▼
Q4-2024 $337.047M ▲ $658.437M ▲ $-207.993M ▲ $-426.76M ▼ $20.155M ▲ $412.492M ▲
Q3-2024 $258.714M $332.977M $-265.637M $-89.65M $-19.222M $85.045M

Revenue by Products

Product Q3-2024Q4-2024Q1-2025Q2-2025
Acute Care Hospital Services
Acute Care Hospital Services
 $2.25Bn ▲$2.32Bn ▲$2.35Bn ▲$2.40Bn ▲
Behavioral Health Services
Behavioral Health Services
 $1.71Bn ▲$1.79Bn ▲$1.75Bn ▼$1.88Bn ▲
All Other Segments
All Other Segments
 $0 ▲$0 ▲$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement Universal Health Services has grown its revenue steadily over the past five years, with both its hospital and behavioral health operations contributing to a larger overall business. Profitability dipped a few years ago as costs rose faster than revenue, but margins have since recovered and now look healthier than earlier in the period. Earnings have rebounded well, suggesting better cost control, improved payer mix, and more efficient operations. The trend points to a company that has worked through a rough patch and is now converting a growing top line into more solid bottom‑line performance, though it still operates in a cost‑pressured, highly regulated industry.

Balance Sheet

Balance Sheet The balance sheet looks fairly stable and typical for a large hospital operator. Total assets have inched up over time, and shareholders’ equity has gradually grown, which is a positive sign for underlying business value. Debt is meaningful but not extreme for this type of capital‑intensive business, and it has recently moved from rising to slightly easing. Cash on hand is relatively lean compared with the size of the company, which makes access to credit and consistent cash generation important. Overall, leverage and asset levels appear manageable, but the company does not have an overly cushioned balance sheet and must continue to carefully manage debt and capital spending.

Cash Flow

Cash Flow Cash generation has been somewhat up and down, but the general direction over the period is favorable. A few years ago, operating cash flow weakened, likely reflecting pandemic‑related disruptions, labor pressures, and working capital swings. Since then, cash from operations has strengthened meaningfully, and free cash flow has improved from nearly breakeven to a more comfortable surplus. Capital spending has stayed fairly steady, indicating ongoing investment in facilities and technology rather than aggressive cutbacks. The pattern suggests a business that is regaining financial flexibility, but with cash flows that can still fluctuate with reimbursement timing, wage costs, and occupancy trends.

Competitive Edge

Competitive Edge UHS holds a solid, though not unassailable, competitive position. It is one of the larger hospital and behavioral health operators in the U.S., which brings brand recognition, negotiating leverage with payers, and scale benefits. Regulation and licensing requirements create real barriers to new entrants, supporting an advantage for established players like UHS. A key strength is its sizable behavioral health footprint, where demand is structurally growing and competition is more specialized. At the same time, UHS faces ongoing headwinds: intense competition from other large hospital systems, continued pressure from government and commercial payers, and challenges around staffing and labor costs. The result is a “narrow moat” situation—noticeable strengths, but not immunity from industry pressures.

Innovation and R&D

Innovation and R&D The company is leaning into digital and data‑driven tools to sharpen its edge. A unified electronic health record platform across acute and behavioral facilities should improve clinical coordination, safety, and efficiency over time. Use of technologies like ObservSMART in behavioral health facilities enhances patient monitoring and compliance, potentially reducing adverse events and labor strain. UHS is also experimenting with artificial intelligence, including a partnership focused on safe, non‑diagnostic applications such as patient communication and administrative workflow. Beyond technology, its Medicare Advantage health plan and physician management arm deepen integration across the care continuum. These initiatives signal a management team investing in modern infrastructure and new care models, though the financial and operational payoffs will depend on execution quality and adoption by clinicians and patients.

Summary

Overall, Universal Health Services presents as a mature, steadily growing healthcare operator that has navigated through cost and cash‑flow volatility to re‑establish stronger profitability. Revenue and earnings trends are constructive, the balance sheet is reasonably sound for a hospital‑heavy business, and free cash flow has improved after a weaker stretch. Its competitive footing is supported by scale, regulatory barriers, and a strong behavioral health presence, but it remains exposed to reimbursement risk, labor shortages, and ongoing industry disruption. The company’s push into digital health, AI, and integrated care platforms adds a forward‑looking element that could enhance efficiency and patient experience over time, while also introducing some execution risk. In short, UHS appears to be a solid but still evolving operator in a challenging, policy‑sensitive sector.

NEWS

November 18, 2025 · 4:20 PM UTC

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND

Read more

October 29, 2025 · 4:15 PM UTC

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT THE 2025 WOLFE RESEARCH HEALTHCARE CONFERENCE

Read more

October 27, 2025 · 4:16 PM UTC

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2025, INCREASES 2025 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1.5 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION

Read more

October 8, 2025 · 4:15 PM UTC

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR THIRD QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

Read more

September 15, 2025 · 12:00 PM UTC

Universal Health Services, Inc. Appoints Darren Lehrich as Vice President of Investor Relations

Read more